ArticleClinical pharmacology and therapeutics2022

Biomarkers for Predicting Abiraterone Treatment Outcome and Selecting Alternative Therapies in Castration-Resistant Prostate Cancer.

Sisi Qin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.